Background: Testicular tumours are very rare in children. Germ cell tumours (GCTs) account for the majority of testicular tumours in young people, and embryonal carcinomas are a common component of GCTs in adolescents. Case Presentation: A 9.8-year-old boy presented with the development of pubic and facial hair over a period of 2 years. He had a growth spurt and examination revealed pubertal staging of G4 P4 A2 with a 6-mls testis on the right and a 4-mls testis on the left. Investigations revealed suppressed gonadotrophins, a testosterone concentration of 10.3 nmol/l and normal 17-hydroxyprogesterone and adrenal androgen levels. Tumour markers were negative. Following treatment with anastrazole, his height velocity slowed down. At the age of 13.7 years, his treatment was stopped. At the age of 14.8 years, he presented with a grossly enlarged right testis and elevated beta human chorionic gonadotrophin (>1,400 IU/l). He underwent right orchidectomy and histology revealed an embryonal carcinoma with no vascular invasion. Analysis of luteinizing hormone/choriogonadotrophin receptor revealed no mutation. Conclusion: We present a case of testicular embryonal carcinoma in a boy who had presented 5 years before with features suggestive of gonadotrophin-independent precocious puberty.

1.
Brunner HG, Otten BJ: Precocious puberty in boys. N Engl J Med 1999;341:1763-1765.
2.
Laue L, Kenigsberg D, Pescovitz OH, Hench KD, Barnes KM, Loriaux DL, Cutler GB: Treatment of familial male precocious puberty with spironolactone and testolactone. N Engl J Med 1989;320:496-502.
3.
Shenker A, Laue L, Kosugi S, Merendino JJ, Minegishi T, Cutler GB: A constitutively activating mutation of the luteinizing hormone receptor in familial male precocious puberty. Nature 1993;365:652-654.
4.
Kraaij R, Post M, Kremer H, Milgrom E, Epping W, Brunner HG, Grootegoed JA, Themmen AP: A missense mutation in the second transmembrane segment of the luteinizing hormone receptor causes familial male-limited precocious puberty. J Clin Endocrinol Metab 1995;80:3168-3172.
5.
Themmen AP, Brunner HG: Luteinizing hormone receptor mutations and sex differentiation. Eur J Endocrinol 1996;134:533-540.
6.
Chan WY: Molecular, genetic, biochemical and clinical implications of gonadotropin receptor mutations. Mol Genet Metab 1998;63:75-84.
7.
Kiepe D, Richter-Unruh A, Autschbach F, Kessler M, Schenk JP, Bettendorf M: Sexual pseudo-precocity caused by a somatic activating mutation of the LH receptor preceding true sexual precocity. Horm Res 2008;70:249-253.
8.
Liu G, Duranteau L, Carel JC, Monroe J, Doyle DA, Shenker A: Leydig-cell tumors caused by an activating mutation of the gene encoding the luteinizing hormone receptor. N Engl J Med 1999;341:1731-1736.
9.
Leschek EW, Chan WY, Diamond DA, Kaefer M, Jones J, Barnes KM, Cutler GB: Nodular Leydig cell hyperplasia in a boy with familial male-limited precocious puberty. J Pediatr 2001;138:949-951.
10.
Richter-Unruh A, Wessels HT, Menken U, Bergmann M, Schmittmann-Ohters K, Schaper J, Tappeser S, Hauffa BP: Male LH-independent sexual precocity in a 3.5-year-old boy caused by a somatic activating mutation of the LH receptor in a Leydig cell tumor. J Clin Endocrinol Metab 2002;87:1052-1056.
11.
Ghazi AA, Rahimi F, Ahadi MM, Sadeghi-Nejad A: Development of true precocious puberty following treatment of a Leydig cell tumor of the testis. J Pediatr Endocrinol Metab 2001;14:1679-1681.
12.
Francisco B. Nogueira Neto ASP, Carla R, Macedo PD, Eliana M, Caran M: Testicular tumors in children and adolescents. J Pediatr (Rio J) 2012;88:87-92.
13.
Ahmed HU, Arya M, Muneer A, Mushtaq I, Sebire NJ: Testicular and paratesticular tumours in the prepubertal population. Lancet Oncol 2010;11:476-483.
14.
Ciftci AO, Bingöl-Koloğlu M, Senocak ME, Tanyel FC, Büyükpamukçu M, Büyükpamukçu N: Testicular tumors in children. J Pediatr Surg 2001;36:1796-1801.
15.
Bahrami A, Ro JY, Ayala AG: An overview of testicular germ cell tumors. Arch Pathol Lab Med 2007;131:1267-1280.
16.
Taskinen S, Fagerholm R, Aronniemi J, Rintala R, Taskinen M: Testicular tumors in children and adolescents. J Pediatr Urol 2008;4:134-137.
17.
Martin MM, Wu SM, Martin AL, Rennert OM, Chan WY: Testicular seminoma in a patient with a constitutively activating mutation of the luteinizing hormone/chorionic gonadotropin receptor. Eur J Endocrinol 1998;139:101-106.
18.
Metcalfe PD, Farivar-Mohseni H, Farhat W, McLorie G, Khoury A, Bägli DJ: Pediatric testicular tumors: contemporary incidence and efficacy of testicular preserving surgery. J Urol 2003;170:2412-2415.
19.
Sugita Y, Clarnette TD, Cooke-Yarborough C, Chow CW, Waters K, Hutson JM: Testicular and paratesticular tumours in children: 30 years' experience. Aust N Z J Surg 1999;69:505-508.
20.
Yuan X, Wei G, Lin T, He D, Li X: Uncommon pediatric painless scrotal masses: a puzzle of pediatricians and urologists. Int Urol Nephrol 2010;42:979-984.
21.
Ross JH, Kay R: Prepubertal testis tumors. Rev Urol 2004;6:11-18.
22.
Winston K, Stein R: Mixed germ cell tumour after testotoxicosis. Clin Endocrinol (Oxf) 2014, Epub ahead of print.
23.
Ross JH, Rybicki L, Kay R: Clinical behavior and a contemporary management algorithm for prepubertal testis tumors: a summary of the prepubertal testis tumor registry. J Urol 2002;168:1675-1678.
24.
Venturelli E, Coradini D, Gornati D, Secreto G: Growth stimulatory effect and metabolism of testosterone in MCF-7 human breast cancer cells. Int J Oncol 1996;8:687-692.
25.
Van Sande J, Parma J, Tonacchera M, Swillens S, Dumont J, Vassart G: Somatic and germline mutations of the TSH receptor gene in thyroid diseases. J Clin Endocrinol Metab 1995;80:2577-2585.
26.
Kocaoğlu M, Bozlar U, Bulakbaşi N, Sağlam M, Uçöz T, Somuncu I: Testicular microlithiasis in the pediatric age group: ultrasonography findings and literature review. Diagn Interv Radiol 2005;11:60-65.
27.
Kwan DJ, Kirsch AJ, Chang DT, Goluboff ET, Berdon WE, Hensle TW: Testicular microlithiasis in a child with torsion of the appendix testis. J Urol 1995;153:183-184.
28.
Dell'Acqua A, Tomà P, Oddone M, Ciccone MA, Marsili E, Derchi LE: Testicular microlithiasis: US findings in six pediatric cases and literature review. Eur Radiol 1999;9:940-944.
29.
Leenen AS, Riebel TW: Testicular microlithiasis in children: sonographic features and clinical implications. Pediatr Radiol 2002;32:575-579.
30.
Furness PD, Husmann DA, Brock JW, Steinhardt GF, Bukowski TP, Freedman AL, Silver RI, Cheng EY: Multi-institutional study of testicular microlithiasis in childhood: a benign or premalignant condition? J Urol 1998;160:1151-1154.
31.
Cooper ML, Kaefer M, Fan R, Rink RC, Jennings SG, Karmazyn B: Testicular microlithiasis in children and associated testicular cancer. Radiology 2013;21:130394.
32.
McEniff N, Doherty F, Katz J, Schrager CA, Klauber G: Yolk sac tumor of the testis discovered on a routine annual sonogram in a boy with testicular microlithiasis. AJR Am J Roentgenol 1995;164:971-972.
33.
Slaughenhoupt B, Kadlec A, Schrepferman C: Testicular microlithiasis preceding metastatic mixed germ cell tumor - first pediatric report and recommended management of testicular microlithiasis in the pediatric population. Urology 2009;73:1029-1031.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.